Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p><br /></p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="vertical-align: top ; "> </td><td style="vertical-align: top ; ">&#8226; </td><td style="text-align: justify ; vertical-align: middle; vertical-align: top ; ">First study of Allocetra^TM in thumb osteoarthritis, a debilitating disease that...